PDUFA public meeting
This article was originally published in The Tan Sheet
Executive Summary
FDA will host a public meeting to gather stakeholder feedback on the Prescription Drug User Fee Act (PDUFA) Nov. 14 from 9 a.m. to 5 p.m. The agency requests that the public consider two questions in preparation for the meeting or submitted comments: "What is your assessment of the overall performance of the PDUFA programs thus far?" and "What aspects of PDUFA should be retained, or what should be changed to further strengthen and improve the program?" Current PDUFA legislation will expire in September 2007. Those planning to attend the meeting must be registered by Oct. 31 and written comments must be submitted by Dec. 14, FDA states...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.